Skip to main content
Brainsway Ltd. logo

Brainsway Ltd. — Investor Relations & Filings

Ticker · BWAY ISIN · US10501L1061 US Manufacturing
Open in API
Filings indexed 245 across all filing types
Latest filing 2026-05-18 Regulatory Filings
Country US United States of America
Listing US BWAY

About Brainsway Ltd.

https://www.brainsway.com/

Brainsway Ltd. is a medical device company that develops and markets advanced noninvasive neurostimulation treatments for mental health disorders. The company's core technology is Deep Transcranial Magnetic Stimulation (Deep TMS), which utilizes a patented H-coil to stimulate deeper and broader regions of the brain. This technology is designed as a medication-free treatment option. Brainsway has received FDA clearance for its Deep TMS system for several conditions, including Major Depressive Disorder (MDD), Anxious Depression, Obsessive-Compulsive Disorder (OCD), and as an aid for short-term smoking cessation. The OCD clearance was the first for a noninvasive medical device, and the smoking cessation clearance was the first in the addiction space for any TMS device.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 87% confidence The document is clearly a Form 6-K (“Report of Foreign Private Issuer”) submitted under the Securities Exchange Act. It includes an exhibit index and signature block for compliance purposes. There is no substantive financial data or earnings discussion—it is a routine regulatory filing. Under our taxonomy, such SEC filings that do not fit other specific categories (e.g., Form 6-K) are classified as Regulatory Filings (RNS).
2026-05-18 English
6-K - Brainsway Ltd. (0001505065) (Filer)
Regulatory Filings Classification · 90% confidence The document is a Form 6-K (SEC report of a foreign private issuer) with an exhibit index listing an investor deck (Exhibit 99.1). It does not contain substantive financial data or management discussion itself but serves as a regulatory filing to make available the investor presentation. Under the classification scheme, standalone SEC forms such as 6-K are categorized as Regulatory Filings (RNS).
2026-05-13 English
6-K - Brainsway Ltd. (0001505065) (Filer)
Regulatory Filings Classification · 72% confidence The document is a SEC Form 6-K filed by a foreign private issuer, which serves as a regulatory filing to report the attached press release. The text provided is only the cover page and Exhibit Index, with no actual financial statements or detailed results. Under our taxonomy, a Form 6-K is a general regulatory announcement and does not constitute the full report (e.g., earnings release) itself. Therefore it should be classified under Regulatory Filings (RNS).
2026-05-13 English
20-F - Brainsway Ltd. (0001505065) (Filer)
Annual Report FY 2025
2026-04-20 English
6-K - Brainsway Ltd. (0001505065) (Filer)
Regulatory Filings
2026-04-15 English
6-K - Brainsway Ltd. (0001505065) (Filer)
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, BrainsWay Ltd., with the SEC. It reports a milestone-based investment related to FDA approval of a product. The document is short (2001 characters) and primarily serves as a regulatory announcement of an event rather than a detailed financial report or earnings release. It does not contain financial statements or detailed management discussion. Form 6-K filings are typically considered regulatory filings for foreign issuers to disclose material information. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-03-26 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.